Medulloblastoma is a common and disabling tumor of children, for which current therapies are often ineffective. The transcription factors MYC and MYCN are expressed in the majority of these tumors, but are essentially untargetable. The long-term objective of this application is to integrate genomic screening of human tumors with mouse co-expression networks to identify both new cancer targets, and novel roles for pathways with existing therapeutics. We focus this effort in-part on tissue-specific networks that distinguish MYC and MYCN in in normal murine cerebellum, and in mouse models of MYC and MYCN-driven medulloblastoma. We will filter potential targets through analysis of murine MYC and MYCN driven networks in skin and in skin cancer, and using human genetics and genomic datasets. We present preliminary data utilizing this methodology to identify GABA receptors as novel targets in medulloblasotma. This study establishes a general method of developing murine genetic networks in normal murine somatic and cancer tissues, and applying these as a filter to human cancer, to identify new targets.
Our specific aims are: A1. Develop an integrated bioinformatics screening and mouse models approach to identify cancer targets. We characterized co-expression networks in normal skin, brain, and lung from a large genotyped mouse back- cross, from which 22 tissues are preserved for trans-CTDD projects. A2. Based on data resulting from our integrated mouse-human bioinformatics approach, we will validate GABA receptors as therapeutic targets in MB, and whether bioactive drugs used in neurological and psychiatric disorders can be leveraged therapeutically in this common and lethal childhood cancer. A3. To identify targets associated with MYC and/or MYCN in medulloblastoma. Successful completion identifies MYC and MYCN-associated signature and targets in medulloblastoma, potentially applicable across a spectrum of MYC and MYCN-driven cancers.

Public Health Relevance

Medulloblastoma is a common and debilitating tumor of children, for which current therapies are often ineffective. The cancer genes MYC and MYCN are associated with a majority of these tumors, but are essentially untargetable by any current drug or technology. This application establishes a general method to develop and analyze genetic networks in normal mouse tissues and in mouse models for cancer (focusing here on medulloblastoma), and applying these as a filter to genetic and genomic databases from human cancer, to identify new therapeutic targets.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project--Cooperative Agreements (U01)
Project #
1U01CA176287-01
Application #
8495650
Study Section
Special Emphasis Panel (ZCA1-SRLB-R (J1))
Program Officer
Gerhard, Daniela
Project Start
2013-06-07
Project End
2017-04-30
Budget Start
2013-06-07
Budget End
2014-04-30
Support Year
1
Fiscal Year
2013
Total Cost
$313,833
Indirect Cost
$113,833
Name
University of California San Francisco
Department
Neurology
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Huang, Miller; Miller, Matthew L; McHenry, Lauren K et al. (2016) Generating trunk neural crest from human pluripotent stem cells. Sci Rep 6:19727
Halliwill, Kyle D; Quigley, David A; Kang, Hio Chung et al. (2016) Panx3 links body mass index and tumorigenesis in a genetically heterogeneous mouse model of carcinogen-induced cancer. Genome Med 8:83
Quigley, David A; Kandyba, Eve; Huang, Phillips et al. (2016) Gene Expression Architecture of Mouse Dorsal and Tail Skin Reveals Functional Differences in Inflammation and Cancer. Cell Rep 16:1153-65
Oh, Sekyung; Flynn, Ryan A; Floor, Stephen N et al. (2016) Medulloblastoma-associated DDX3 variant selectively alters the translational response to stress. Oncotarget 7:28169-82
Cancer Target Discovery and Development Network (2016) Transforming Big Data into Cancer-Relevant Insight: An Initial, Multi-Tier Approach to Assess Reproducibility and Relevance. Mol Cancer Res 14:675-82
Chen, Justin; Hackett, Christopher S; Zhang, Shile et al. (2015) The genetics of splicing in neuroblastoma. Cancer Discov 5:380-95
Westcott, Peter M K; Halliwill, Kyle D; To, Minh D et al. (2015) The mutational landscapes of genetic and chemical models of Kras-driven lung cancer. Nature 517:489-92
McCreery, Melissa Q; Halliwill, Kyle D; Chin, Douglas et al. (2015) Evolution of metastasis revealed by mutational landscapes of chemically induced skin cancers. Nat Med 21:1514-20
Yao, Tsun-Wen; Zhang, Jie; Prados, Michael et al. (2015) EGFR blockade prevents glioma escape from BRAFV600E targeted therapy. Oncotarget 6:21993-2005
Chen, J; Weiss, W A (2015) Alternative splicing in cancer: implications for biology and therapy. Oncogene 34:1-14

Showing the most recent 10 out of 25 publications